PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 2017American Journal of Nephrology408 citationsOpen Access

Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes

ACAllan J. CollinsBPBertram PittNRNancy L. Reaven

Structured PICO

Is dyskalemia associated with increased all-cause mortality in patients with and without HF, CKD, and/or DM?

P
Population
Patients with and without Heart Failure (HF), Chronic Kidney Disease (CKD), and/or Diabetes (DM)
I
Intervention
Dyskalemia (abnormal serum potassium)
O
Outcome
All-Cause Mortalityhard clinical

Dyskalemia is associated with an increased risk of all-cause mortality, with a more pronounced effect in patients with heart failure, chronic kidney disease, or diabetes.

Abstract

Mortality risk progressively increased with dyskalemia and was differentially greater in those with HF, CKD, or DM.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Collins et al. (2017) studied this question.

synapsesocial.com/papers/69d5755223f4decff7b4cce4https://doi.org/10.1159/000479802
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods2006 · 472 citations
  2. 2Hypokalemia, Its Contributing Factors and Renal Outcomes in Patients with Chronic Kidney Disease2013 · 67 citations
  3. 3A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure2007 · 188 citations
  4. 4Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors2014 · 674 citations
  5. 5Sodium Zirconium Cyclosilicate in Hyperkalemia2014 · 505 citations